Citral

Citral

SCHEMBL1865532

CC(C)=CCC/C(C)=C/C=O.CC(C)=CCC/C(C)=C/C=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 1.00
KMT2A Q03164 3/20 0.58
ALOX15 P16050 3/20 0.54
MEN1 O00255 2/20 0.54
CYP3A4 P08684 2/20 0.54
KDM4E B2RXH2 2/20 0.54
ATM Q13315 1/20 0.54
NR1I2 O75469 1/20 0.53
LMNA P02545 1/20 0.53
PGR P06401 1/20 0.53
MAPT P10636 2/20 0.52
UGT1A1 P22309 1/20 0.52
POLB P06746 1/20 0.52
SQLE Q14534 2/20 0.50
FNTA P49354 1/20 0.47
FNTB P49356 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citral SCHEMBL2869016 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AALOX15MEN1CYP3A4
Citral SCHEMBL3632554 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AALOX15MEN1CYP3A4
Citral SCHEMBL23073 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AALOX15MEN1CYP3A4
Citral SCHEMBL14977211 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AALOX15MEN1CYP3A4
Citral SCHEMBL19357313 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AALOX15MEN1CYP3A4
Citral SCHEMBL23074 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AALOX15MEN1CYP3A4
Citral SCHEMBL3643082 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AALOX15MEN1CYP3A4
Citral SCHEMBL21491 1.00 ALDH1A1 (1.00) ALDH1A1KMT2AALOX15MEN1CYP3A4
Citral SCHEMBL30931693 0.98 ALDH1A1 (0.95) ALDH1A1KMT2AALOX15MEN1CYP3A4
Citral SCHEMBL11328102 0.98 ALDH1A1 (0.95) ALDH1A1KMT2AALOX15MEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230211311-A1 SYSTEMS AND METHODS FOR PROCESSING GASES TRANSF MATERIALS LLC (US) 2023-07-06 US disclosed
US-11633710-B2 Systems and methods for processing gases TRANSFORM MATERIALS LLC (US) 2023-04-25 US disclosed
CN-111388611-B Method for extracting total flavonoids from lemongrass 云南省农业科学院热区生态农业研究所 2022-01-28 CN disclosed
US-20210245133-A1 SYSTEMS AND METHODS FOR PROCESSING GASES CARBOGENESIS LLC 2021-08-12 US disclosed
CN-111388611-A Method for extracting total flavonoids from lemongrass 云南省农业科学院热区生态农业研究所 2020-07-10 CN disclosed
US-20200211703-A1 LIQUID DISPENSING SYSTEM CREATING AND MAINTAINING A PERSONALIZED BUBBLE WITH A DEFINED RADIUS AND CONCENTRATION SENSORY DESIGN & TECHNOLOGY LTD (GB) 2020-07-02 US disclosed
EP-3430111-A1 PERFUME COMPOSITIONS Givaudan SA (CH) 2019-01-23 EP disclosed
WO-2017157985-A1 PERFUME COMPOSITIONS GIVAUDAN SA (CH) 2017-09-21 WO disclosed
US-9669241-B2 Waterless animal bath ASCENT IP HOLDINGS, LLC (US) 2017-06-06 US disclosed
US-20140242021-A1 Waterless Animal Bath SIRIUS PRODUCTS, INC. (US) 2014-08-28 US disclosed
EP-2496682-A1 DELIVERY PARTICLE The Procter & Gamble Company (US) 2012-09-12 EP disclosed
WO-2011056935-A1 DELIVERY PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2011-05-12 WO disclosed
WO-2007038524-A2 COCRYSTALLIZATION METHODS SSCI, INC. (US) 2007-04-05 WO disclosed
US-6001410-A TOGETHER WITH SCLAREOLIDE AND/OR SUCCINIC ACID FOR ENHANCING THE ALCOHOLIC IMPACT OF A FRUIT LIQUEUR BEVERAGE. INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1999-12-14 US disclosed
EP-0301375-B1 BICYCLIC ALDEHYDES L. GIVAUDAN & CIE Société Anonyme (CH) 1992-03-18 EP disclosed
US-3997610-A DISTILLATION, METAL BORATE RHONE-POULENC S.A. (FR) 1976-12-14 US disclosed
US-3971830-A PALLADIUM CATALYST RHODIA, INC. (US) 1976-07-27 US disclosed
US-3971831-A PALLADIUM CATALYST RHONE-POULENC S.A. (FR) 1976-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230211311-A1 SYSTEMS AND METHODS FOR PROCESSING GASES F2, AHR, ACSS2 ALDH1A1 4082/4885KMT2A 4023/4885ALOX15 193/4885
US-20210245133-A1 SYSTEMS AND METHODS FOR PROCESSING GASES F2, AHR, ACSS2 ALDH1A1 4082/4885KMT2A 4023/4885ALOX15 193/4885
US-11633710-B2 Systems and methods for processing gases F2, AHR, ACSS2 ALDH1A1 4082/4885KMT2A 4023/4885ALOX15 193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.